[1]JournalofMedicinalChemistry,2011,vol.54,p.7299-7317
[2]Patent:US2016/24060,2016,A1
[1]Patent:WO2016/100184,2016,A1.Locationinpatent:Paragraph00677-00678
849758-12-9
222978-01-0
1256276-36-4
1951439-57-8
1383985-25-8
842167-67-3
1630906-46-5 | tert-Butyl 2-([(tert-butyldiphenylsilyl)oxy]methyl)-4-formylpiperidine-1-carboxylate | AA001TMD | MFCD28502559
163295-75-8 | 4-Trifluoromethylbenzylsulfonyl chloride | AA001TX8 | MFCD01631932
163679-35-4 | (S)-2,5-Dioxopyrrolidin-1-yl 2-((tert-butoxycarbonyl)amino)-3-(4-hydroxy-3,5-diiodophenyl)propanoate | AA001U8D | MFCD00057897
1638772-09-4 | Methyl cis-5-methylpiperidine-3-carboxylate hydrochloride | AA001UFT | MFCD28501411
164391-47-3 | Piperidine, 4-(1H-imidazol-5-ylmethyl)-, hydrobromide (1:2) | AA001US7 | MFCD06407876
16495-40-2 | Butanoic acid, 2-bromo-3,3-dimethyl-, methyl ester | AA001V3X | MFCD24476606
1609402-14-3 | Ha15 | AA001VG5 | MFCD30377202
161696-76-0 | 2-Methyl-4-(piperazin-1-yl)-10H-benzo[b]thieno[2,3-e][1,4]diazepine | AA001VPN | MFCD09840321
16534-12-6 | 4-Bromo-3,5-dihydroxybenzoic acid | AA001W14 | MFCD00002513
16582-59-5 | 2-Amino-4,6-dichlorobenzothiazole | AA001WAP | MFCD01123002